Has Kristina Bonesteel received payments from drug or device companies?

Yes. Drug and device makers reported $9,472 in general payments to Kristina Bonesteel across 422 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kristina Bonesteel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kristina Bonesteel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kristina Bonesteel

Nurse Practitioner · Bryn Mawr, PANPI 1972969426

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.0% of the total across 422 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,472in general payments, 2019–2025

Across 422 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$966
Daiichi Sankyo Inc.$662
AstraZeneca$640
Novartis$602
AbbVie$381
Servier Pharmaceuticals LLC$354
plus $6K from 54 others

What the payments were for

Food & beverage$8,81393%
Education$6587%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	32	$966
Daiichi Sankyo Inc.	29	$662
AstraZeneca(2 entities)	32	$640
Novartis	35	$602
AbbVie	20	$381
Servier Pharmaceuticals LLC	10	$354
Takeda Pharmaceuticals U.S.A., Inc.	15	$349
Astellas Pharma US Inc	19	$336
Pharmacyclics LLC, An Abbvie Company	14	$319
Bayer	12	$318
Incyte Corporation	8	$278
Gilead(2 entities)	5	$266
Bristol Myers Squibb	13	$247
E.r. Squibb & Sons, L.L.C.	10	$231
Genentech USA, Inc.	11	$205
Eisai Inc.	9	$193
Amgen	9	$187
Pfizer	10	$175
Ipsen Biopharmaceuticals, Inc	7	$156
Pharmacosmos Therapeutics Inc.	7	$150
Merck	7	$144
GSK	5	$136
Sanofi	6	$125
Celltrion USA Inc.	1	$101
Regeneron Healthcare Solutions, Inc.	5	$99
Morphosys, US Inc.	4	$88
Pharmaessentia USA Corporation	4	$87
Boehringer Ingelheim	4	$85
Sobi, Inc	4	$80
Array Biopharma Inc	4	$78
Tersera Therapeutics LLC	4	$76
AVEO Pharmaceuticals, Inc.	4	$76
Lilly USA, LLC	4	$75
Amneal Pharmaceuticals LLC	3	$70
Genmab U.S., Inc.	3	$69
Jazz Pharmaceuticals Inc.	3	$68
Puma Biotechnology, Inc.	3	$64
Stemline Therapeutics Inc.	3	$60
Seagen Inc.	3	$53
Coherus Oncology, Inc.	3	$48
Beone Medicines USA, Inc.	2	$48
Boston Scientific	2	$47
Karyopharm Therapeutics Inc.	2	$45
EMD Serono, Inc.	2	$45
Spectrum Pharmaceuticals Inc.	2	$44
Caris MPI, Inc.	2	$43
Exelixis Inc.	2	$42
Taiho Oncology, Inc.	2	$42
Apellis Pharmaceuticals, Inc.	2	$41
Beigene USA, Inc.	2	$41
Zydus Pharmaceuticals (USA) Inc.	2	$40
Agios Pharmaceuticals, Inc.	2	$38
Helsinn Therapeutics (U.S.), Inc.	2	$33
Mirati Therapeutics, Inc.	2	$32
ADC Therapeutics America, Inc.	1	$28
Adaptive Biotechnologies Corporation	1	$27
Fresenius Kabi USA, LLC	1	$24
Sandoz	1	$22
G1 Therapeutics, Inc.	1	$19
Clovis Oncology, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,472 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	15	$206
Tramadol Hcl	15	$115
Lorazepam	18	$65

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Bryn Mawr

Susan SpadtBryn Mawr$26K
Gina PagottoBryn Mawr$11K
Awilda RodriguezBryn Mawr$10K
Patricia ManganPhiladelphia$360K
Lisa CocoPhiladelphia$230K
Elisabeth BaidalPhiladelphia$151K
Suzanne McGettiganPhiladelphia$108K
Tracey WileyChambersburg$101K
Pamela LorditchJohnstown$81K
Nana BernaskoHershey$81K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →